7 Ways Medical Marijuana, Inc. Has Promoted Cannabinoid Use Worldwide

[vc_row][vc_column][vc_column_text]Medical Marijuana, Inc. has dedicated itself to the monumental task of bringing access to cannabinoids to everyone in the world, regardless of geographical location, financial means, or local laws. To complete this mission, Medical Marijuana, Inc. and its portfolio of companies have worked to motivate cannabis reform, to educate doctors and lawmakers on the benefits of cannabinoids, and to create products that can safely and reliably provide our customers with the cannabinoids they seek.

1. Creating a Legal CBD Pipeline

Before we could begin creating our CBD hemp oil products, we needed to discover the right hemp cultivar for our needs. After testing 3000 possible hemp plants, we found the one that would thrive in the soil on our Northern European farms and generate the ideal ratio of cannabinoids required for our products.

Since our CBD hemp oil is derived from hemp that contains less than 0.3 percent THC, we are able to import it into the U.S. to be formulated into our complete line of CBD hemp oil products. Grown free of chemical fertilizers, herbicides, or pesticides, our hemp is thoroughly vetted in our Triple Lab Tested® process. It is this choice to work with hemp over marijuana that allows us to promote our cannabinoid-based hemp oil products to a wide audience.

2. Shipping to 50 States and Over 40 Countries

Regardless of local medical marijuana laws, Medical Marijuana, Inc. is able to ship our products throughout the U.S. and to over 40 countries internationally. We are able to do this for a number of reasons. First, because we make our products from non-psychoactive hemp instead of high-THC marijuana, we are not subject to the same strict legal restrictions as marijuana. Second, we sell our products as wellness products, meaning that our customers do not need to live in a medical marijuana state or obtain a doctor’s recommendation before starting with our cannabinoid products, easing the basic barriers to accessing cannabinoids that many people in this world face. [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_single_image image=”17298″ img_size=”1200×250″ onclick=”custom_link” link=”https://www.medicalmarijuanainc.com/why-do-we-refer-to-hemp-as-industrial-hemp/”][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]

3. Opening Latin American Markets

Medical Marijuana, Inc.’s Real Scientific Hemp Oil™ (RSHO™) was the first product approved for import in three Latin American countries – Brazil, Mexico, and Paraguay. Addressing a need for cannabis-based products in these counties, Medical Marijuana, Inc. subsidiary HempMeds® set up local branches to help educate doctors, lawmakers, and families on the beneficial effects of CBD. Working with grassroots efforts in these countries, HempMeds® Brasil and HempMeds® Mexico secured the right to be the first to ship CBD hemp oil into Latin America and bring access to cannabidiol to 320 million more people.

Customers in Brazil and Mexico who are interested in using cannabidiol can visit the HempMeds® Brasil and HempMeds® Mexico websites to get the information they need to start importing our hemp oil products.

4. Raising Awareness for Cannabinoids at National and International Events

The Medical Marijuana, Inc. team and their portfolio of companies regularly attend cannabis, health and wellness, and business themed events to maximize the exposure of our brands and to educate the public on the many benefits of integrating cannabinoids into their systems. Through our booths on the event’s exposition floors and participation in forums and educational panels, our company’s leadership and product specialists are able to reach out to and connect with those who are curious about CBD hemp oil and the cannabis market. As an industry leader, our presence at these events is critical in promoting our goal of “access for all” through increased awareness and expanded availability.

5. Using Word of Mouth to Expand Interest in CBD

There is no more trusted an opinion as that of a close friend. It is this concept that drives the word of mouth marketing that takes place within the Kannaway® network. By tapping into this fluid system of personal connections, Kannaway® is able to reach in a positive way those who might never become exposed to the possible benefits of cannabinoids. Selling a range of CBD hemp oil products through their team of Kannaway® brand ambassadors, the company is able to promote CBD use for health and balance through all levels of society.

Learn more about Kannaway® and how to become a brand ambassador here. [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_single_image image=”18038″ img_size=”1200×250″ onclick=”custom_link” link=”https://www.medicalmarijuanainc.com/what-is-cbd-oil/”][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]

6. Supporting Legalization Efforts

Medical Marijuana, Inc. promotes access to all cannabinoids, including THC, recognizing potential social and medical advantages in all of the cannabis plant’s properties. Because of this, we have supported legalization efforts like Proposition 64 in our home state of California. Proposition 64 would legalize the adult use of recreational marijuana in the state, increasing access to cannabis and ending the incarceration of low-level and non-violent drug offenders.

The normalization of cannabis use and the acceptance of cannabinoids drives Medical Marijuana, Inc. to support medical and recreational use legalization here in the U.S. and around the globe to secure safe access to cannabis for everyone.

7. Undertaking Clinical Research Studies

Lawmakers, regulators, and health officials at all levels of the government have decried a lack of research surrounding the cannabis plant as a central reason to opposing its legalization and use. To fulfill this urgent need for controlled clinical trials surrounding the cannabis plant and prove the safety and efficacy behind its use, two of Medical Marijuana, Inc.’s portfolio companies, AXIM Biotechnologies® and Kannalife™ Sciences, are actively pursuing clinical trials for their products with the possible end result of receiving new drug status from the FDA or its European equivalent, the European Medicines Agency. Once these companies receive approval from these agencies, their cannabis-based medicines will be available for prescription across the U.S. and Europe, respectively. Proving the usefulness of CBD and other cannabinoids for the treatment of specific conditions in a clinical setting will help further the acceptance of cannabis for medical uses and support the call for its legalization and widespread use. [/vc_column_text][/vc_column][/vc_row]